HEADER HYDROLASE 01-NOV-06 2J92 TITLE 3C PROTEASE FROM TYPE A10(61) FOOT-AND-MOUTH DISEASE VIRUS - CRYSTAL TITLE 2 PACKING MUTANT (K51Q) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PICORNAIN 3C; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTEASE 3C, P3C, PROTEASE P20B, 3C PROTEASE; COMPND 5 EC: 3.4.22.28; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: K51Q - TO DISRUPT ORIGINAL CRYSTAL PACKING C95K - TO COMPND 9 AVOID AGGREGATION C142S - TO AVOID AGGREGATION C163A - TO REMOVE COMPND 10 ACITVE-STE NUCLEOPHILE. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: FOOT-AND-MOUTH DISEASE VIRUS (STRAIN A10-61); SOURCE 3 ORGANISM_TAXID: 12112; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_VECTOR: MODIFIED PETM-11 KEYWDS FOOT-AND- MOUTH DISEASE VIRUS, CHYMOTRYPSIN-LIKE CYSTEINE PROTEASE, KEYWDS 2 HYDROLASE, THIOL PROTEASE, RNA REPLICATION EXPDTA X-RAY DIFFRACTION AUTHOR T.R.SWEENEY,J.R.BIRTLEY,R.J.LEATHERBARROW,S.CURRY REVDAT 3 13-DEC-23 2J92 1 REMARK REVDAT 2 24-FEB-09 2J92 1 VERSN REVDAT 1 21-DEC-06 2J92 0 JRNL AUTH T.R.SWEENEY,N.ROQUE-ROSELL,J.R.BIRTLEY,R.J.LEATHERBARROW, JRNL AUTH 2 S.CURRY JRNL TITL STRUCTURAL AND MUTAGENIC ANALYSIS OF FOOT-AND-MOUTH DISEASE JRNL TITL 2 VIRUS 3C PROTEASE REVEALS THE ROLE OF THE {BETA}-RIBBON IN JRNL TITL 3 PROTEOLYSIS. JRNL REF J.VIROL. V. 81 115 2007 JRNL REFN ISSN 0022-538X JRNL PMID 17065215 JRNL DOI 10.1128/JVI.01587-06 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.R.BIRTLEY,S.R.KNOX,A.M.JAULENT,P.BRICK,R.J.LEATHERBARROW, REMARK 1 AUTH 2 S.CURRY REMARK 1 TITL CRYSTAL STRUCTURE OF FOOT-AND-MOUTH DISEASE VIRUS 3C REMARK 1 TITL 2 PROTEASE: NEW INSIGHTS INTO CATALYTIC MECHANISM AND CLEAVAGE REMARK 1 TITL 3 SPECIFICITY REMARK 1 REF J.BIOL.CHEM. V. 280 11520 2005 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 15654079 REMARK 1 DOI 10.1074/JBC.M413254200 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MLF REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.59 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1483613.080 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 20549 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 998 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3190 REMARK 3 BIN R VALUE (WORKING SET) : 0.3860 REMARK 3 BIN FREE R VALUE : 0.3920 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 157 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.031 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2818 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 109 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.37000 REMARK 3 B22 (A**2) : -4.31000 REMARK 3 B33 (A**2) : -2.06000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.31 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.32 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.000 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.630 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 31.30 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2J92 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-NOV-06. REMARK 100 THE DEPOSITION ID IS D_1290030393. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-DEC-05 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX10.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.488 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(III) REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : RH COATED COLLIMATING MIRROR, A REMARK 200 DOUBLE CRYSTAL SI(III) REMARK 200 MONOCHROMATOR WITH HORIZONTAL REMARK 200 SAGGITAL FOCUSING SYSTEM, AND REMARK 200 FINALLY A SECOND RH COATED REMARK 200 MIRROR FOR VERTICAL FOCUSING. REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20590 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 23.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.34000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2BHG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SEE PAPER, PH 7.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.69350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.19950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.85400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 46.19950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.69350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.85400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, LYS 1700 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 1744 TO LYS REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 1791 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 1812 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, LYS 1700 TO GLN REMARK 400 ENGINEERED RESIDUE IN CHAIN B, CYS 1744 TO LYS REMARK 400 ENGINEERED RESIDUE IN CHAIN B, CYS 1791 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN B, CYS 1812 TO ALA REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 0 REMARK 465 SER A 1 REMARK 465 GLY A 2 REMARK 465 ALA A 3 REMARK 465 PRO A 4 REMARK 465 PRO A 5 REMARK 465 THR A 6 REMARK 465 HIS A 208 REMARK 465 GLU B 0 REMARK 465 SER B 1 REMARK 465 GLY B 2 REMARK 465 ALA B 3 REMARK 465 PRO B 4 REMARK 465 PRO B 5 REMARK 465 THR B 6 REMARK 465 ILE B 74 REMARK 465 LYS B 75 REMARK 465 VAL B 76 REMARK 465 LYS B 77 REMARK 465 GLY B 78 REMARK 465 GLN B 79 REMARK 465 ASP B 80 REMARK 465 MET B 81 REMARK 465 VAL B 141 REMARK 465 SER B 142 REMARK 465 MET B 143 REMARK 465 ASP B 144 REMARK 465 GLY B 145 REMARK 465 ASP B 146 REMARK 465 THR B 147 REMARK 465 GLU B 207 REMARK 465 HIS B 208 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 7 CG OD1 OD2 REMARK 470 LYS A 10 CG CD CE NZ REMARK 470 ASP A 24 CG OD1 OD2 REMARK 470 LYS A 26 CG CD CE NZ REMARK 470 LYS A 75 CG CD CE NZ REMARK 470 GLN A 79 CG CD OE1 NE2 REMARK 470 LYS A 95 CG CD CE NZ REMARK 470 ARG A 108 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 110 CG CD CE NZ REMARK 470 LYS A 170 CE NZ REMARK 470 ARG A 196 CD NE CZ NH1 NH2 REMARK 470 GLN A 200 CG CD OE1 NE2 REMARK 470 LYS A 201 CG CD CE NZ REMARK 470 LYS B 26 CG CD CE NZ REMARK 470 ARG B 68 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 73 CG CD OE1 OE2 REMARK 470 ASN B 94 CG OD1 ND2 REMARK 470 ARG B 108 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 110 CG CD CE NZ REMARK 470 LYS B 111 CG CD CE NZ REMARK 470 LYS B 170 CE NZ REMARK 470 LYS B 201 CG CD CE NZ REMARK 470 HIS B 205 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 29 155.26 177.05 REMARK 500 CYS A 31 -168.55 -172.21 REMARK 500 PHE A 48 49.11 -79.74 REMARK 500 ALA A 49 39.65 -158.59 REMARK 500 ASN A 120 94.80 -160.17 REMARK 500 LEU A 134 -109.44 -109.51 REMARK 500 MET A 143 -1.37 -56.93 REMARK 500 ASP B 24 50.09 71.83 REMARK 500 CYS B 31 -171.16 -170.49 REMARK 500 ASN B 120 98.28 -162.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 12-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 13-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ZBA RELATED DB: PDB REMARK 900 FOOT-AND-MOUTH DISEASE VIRUS SEROTYPE A1061 COMPLEXED REMARK 900 WITHOLIGOSACCHARIDE RECEPTOR. REMARK 900 RELATED ID: 1ZBE RELATED DB: PDB REMARK 900 FOOT-AND MOUTH DISEASE VIRUS SEROTYPE A1061 REMARK 900 RELATED ID: 2BHG RELATED DB: PDB REMARK 900 3C PROTEASE FROM TYPE A10(61) FOOT-AND- MOUTH DISEASE VIRUS REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONFLICT ASN1671 (ILE22) ARISES PROBABLY BECAUSE OF A SEQUENCING REMARK 999 ERROR IN THE P03306 ENTRY. COMPARISON OF OVER 40 FMDV 3C SEQUENCES REMARK 999 SHOW THAT ILE 22 IS STRICTLY CONSERVED EXCEPT, APPARENTLY, IN P03306 DBREF 2J92 A 0 206 UNP P03306 POLG_FMDV1 1649 1855 DBREF 2J92 A 207 208 PDB 2J92 2J92 207 208 DBREF 2J92 B 0 206 UNP P03306 POLG_FMDV1 1649 1855 DBREF 2J92 B 207 208 PDB 2J92 2J92 207 208 SEQADV 2J92 ILE A 22 UNP P03306 ASN 1671 CONFLICT SEQADV 2J92 MET A 88 UNP P03306 ILE 1737 CONFLICT SEQADV 2J92 ILE B 22 UNP P03306 ASN 1671 CONFLICT SEQADV 2J92 MET B 88 UNP P03306 ILE 1737 CONFLICT SEQADV 2J92 GLN A 51 UNP P03306 LYS 1700 ENGINEERED MUTATION SEQADV 2J92 LYS A 95 UNP P03306 CYS 1744 ENGINEERED MUTATION SEQADV 2J92 SER A 142 UNP P03306 CYS 1791 ENGINEERED MUTATION SEQADV 2J92 ALA A 163 UNP P03306 CYS 1812 ENGINEERED MUTATION SEQADV 2J92 GLN B 51 UNP P03306 LYS 1700 ENGINEERED MUTATION SEQADV 2J92 LYS B 95 UNP P03306 CYS 1744 ENGINEERED MUTATION SEQADV 2J92 ALA B 163 UNP P03306 CYS 1812 ENGINEERED MUTATION SEQRES 1 A 209 GLU SER GLY ALA PRO PRO THR ASP LEU GLN LYS MET VAL SEQRES 2 A 209 MET GLY ASN THR LYS PRO VAL GLU LEU ILE LEU ASP GLY SEQRES 3 A 209 LYS THR VAL ALA ILE CYS CYS ALA THR GLY VAL PHE GLY SEQRES 4 A 209 THR ALA TYR LEU VAL PRO ARG HIS LEU PHE ALA GLU GLN SEQRES 5 A 209 TYR ASP LYS ILE MET LEU ASP GLY ARG ALA MET THR ASP SEQRES 6 A 209 SER ASP TYR ARG VAL PHE GLU PHE GLU ILE LYS VAL LYS SEQRES 7 A 209 GLY GLN ASP MET LEU SER ASP ALA ALA LEU MET VAL LEU SEQRES 8 A 209 HIS ARG GLY ASN LYS VAL ARG ASP ILE THR LYS HIS PHE SEQRES 9 A 209 ARG ASP THR ALA ARG MET LYS LYS GLY THR PRO VAL VAL SEQRES 10 A 209 GLY VAL VAL ASN ASN ALA ASP VAL GLY ARG LEU ILE PHE SEQRES 11 A 209 SER GLY GLU ALA LEU THR TYR LYS ASP ILE VAL VAL SER SEQRES 12 A 209 MET ASP GLY ASP THR MET PRO GLY LEU PHE ALA TYR LYS SEQRES 13 A 209 ALA ALA THR ARG ALA GLY TYR ALA GLY GLY ALA VAL LEU SEQRES 14 A 209 ALA LYS ASP GLY ALA ASP THR PHE ILE VAL GLY THR HIS SEQRES 15 A 209 SER ALA GLY GLY ASN GLY VAL GLY TYR CYS SER CYS VAL SEQRES 16 A 209 SER ARG SER MET LEU GLN LYS MET LYS ALA HIS VAL GLU SEQRES 17 A 209 HIS SEQRES 1 B 209 GLU SER GLY ALA PRO PRO THR ASP LEU GLN LYS MET VAL SEQRES 2 B 209 MET GLY ASN THR LYS PRO VAL GLU LEU ILE LEU ASP GLY SEQRES 3 B 209 LYS THR VAL ALA ILE CYS CYS ALA THR GLY VAL PHE GLY SEQRES 4 B 209 THR ALA TYR LEU VAL PRO ARG HIS LEU PHE ALA GLU GLN SEQRES 5 B 209 TYR ASP LYS ILE MET LEU ASP GLY ARG ALA MET THR ASP SEQRES 6 B 209 SER ASP TYR ARG VAL PHE GLU PHE GLU ILE LYS VAL LYS SEQRES 7 B 209 GLY GLN ASP MET LEU SER ASP ALA ALA LEU MET VAL LEU SEQRES 8 B 209 HIS ARG GLY ASN LYS VAL ARG ASP ILE THR LYS HIS PHE SEQRES 9 B 209 ARG ASP THR ALA ARG MET LYS LYS GLY THR PRO VAL VAL SEQRES 10 B 209 GLY VAL VAL ASN ASN ALA ASP VAL GLY ARG LEU ILE PHE SEQRES 11 B 209 SER GLY GLU ALA LEU THR TYR LYS ASP ILE VAL VAL SER SEQRES 12 B 209 MET ASP GLY ASP THR MET PRO GLY LEU PHE ALA TYR LYS SEQRES 13 B 209 ALA ALA THR ARG ALA GLY TYR ALA GLY GLY ALA VAL LEU SEQRES 14 B 209 ALA LYS ASP GLY ALA ASP THR PHE ILE VAL GLY THR HIS SEQRES 15 B 209 SER ALA GLY GLY ASN GLY VAL GLY TYR CYS SER CYS VAL SEQRES 16 B 209 SER ARG SER MET LEU GLN LYS MET LYS ALA HIS VAL GLU SEQRES 17 B 209 HIS FORMUL 3 HOH *109(H2 O) HELIX 1 1 ASP A 7 ASN A 15 1 9 HELIX 2 2 THR A 63 SER A 65 5 3 HELIX 3 3 ILE A 99 HIS A 102 5 4 HELIX 4 4 SER A 195 GLU A 207 1 13 HELIX 5 5 ASP B 7 ASN B 15 1 9 HELIX 6 6 HIS B 46 GLU B 50 5 5 HELIX 7 7 THR B 63 SER B 65 5 3 HELIX 8 8 ILE B 99 HIS B 102 5 4 HELIX 9 9 ARG B 159 ALA B 163 5 5 HELIX 10 10 SER B 195 VAL B 206 1 12 SHEET 1 AA 7 ARG A 60 MET A 62 0 SHEET 2 AA 7 LYS A 54 LEU A 57 -1 O ILE A 55 N MET A 62 SHEET 3 AA 7 THR A 16 LEU A 23 -1 O GLU A 20 N MET A 56 SHEET 4 AA 7 LYS A 26 PHE A 37 -1 O LYS A 26 N LEU A 23 SHEET 5 AA 7 ALA A 40 PRO A 44 -1 O ALA A 40 N VAL A 36 SHEET 6 AA 7 GLN A 79 LEU A 90 -1 O ALA A 86 N VAL A 43 SHEET 7 AA 7 TYR A 67 VAL A 76 -1 O ARG A 68 N VAL A 89 SHEET 1 AB13 PRO A 114 ASN A 121 0 SHEET 2 AB13 GLY A 125 ILE A 139 -1 O GLY A 125 N ASN A 121 SHEET 3 AB13 PRO A 149 LYS A 155 -1 N GLY A 150 O ASP A 138 SHEET 4 AB13 VAL A 188 CYS A 193 -1 O GLY A 189 N TYR A 154 SHEET 5 AB13 ASP A 174 GLY A 185 1 O THR A 180 N SER A 192 SHEET 6 AB13 ALA A 166 ASP A 171 -1 O VAL A 167 N VAL A 178 SHEET 7 AB13 PRO A 114 ASN A 121 -1 O VAL A 116 N LEU A 168 SHEET 8 AB13 GLY A 125 ILE A 139 -1 O GLY A 125 N ASN A 121 SHEET 9 AB13 PRO A 149 LYS A 155 -1 N GLY A 150 O ASP A 138 SHEET 10 AB13 VAL A 188 CYS A 193 -1 O GLY A 189 N TYR A 154 SHEET 11 AB13 ASP A 174 GLY A 185 1 O THR A 180 N SER A 192 SHEET 12 AB13 ALA A 166 ASP A 171 -1 O VAL A 167 N VAL A 178 SHEET 13 AB13 PRO A 114 ASN A 121 -1 O VAL A 116 N LEU A 168 SHEET 1 BA 7 ARG B 60 MET B 62 0 SHEET 2 BA 7 LYS B 54 LEU B 57 -1 O ILE B 55 N MET B 62 SHEET 3 BA 7 THR B 16 ILE B 22 -1 O GLU B 20 N MET B 56 SHEET 4 BA 7 THR B 27 PHE B 37 -1 N VAL B 28 O LEU B 21 SHEET 5 BA 7 ALA B 40 PRO B 44 -1 O ALA B 40 N VAL B 36 SHEET 6 BA 7 ALA B 85 LEU B 90 -1 O ALA B 86 N VAL B 43 SHEET 7 BA 7 TYR B 67 GLU B 71 -1 O ARG B 68 N VAL B 89 SHEET 1 BB 2 ALA B 107 MET B 109 0 SHEET 2 BB 2 LYS B 137 ILE B 139 -1 O LYS B 137 N MET B 109 CRYST1 59.387 71.708 92.399 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016839 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013945 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010823 0.00000 MTRIX1 1 -0.922700 0.312900 0.225300 3.91370 1 MTRIX2 1 0.293700 0.948900 -0.115200 -4.34130 1 MTRIX3 1 -0.249900 -0.040100 -0.967400 0.63010 1